Possibilities of Interpreting the Night-to-Day Ratio Specified by 24-hour Blood Pressure Monitoring
ABPM
Seven-day Ambulatory Blood Pressure Monitoring and CAVI in the Prevention of Cardiovascular Diseases
1 other identifier
interventional
171
1 country
1
Brief Summary
Specify the risk rate of incorrect patient classification based on night-to-day ratio specification from singular 24-h ABPM in comparison to the results of 7-day ABPM monitoring
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable cardiovascular-diseases
Started Jun 2018
Typical duration for not_applicable cardiovascular-diseases
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 20, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 25, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
June 20, 2021
CompletedFirst Submitted
Initial submission to the registry
February 9, 2022
CompletedFirst Posted
Study publicly available on registry
March 3, 2022
CompletedMarch 3, 2022
February 1, 2022
2 years
February 9, 2022
February 21, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The risk rate of incorrect patient classification based on night-to-day ratio specification from singular 24-h ABPM in comparison to the results of 7-day ABPM monitoring.
Primary outcome was to specify the risk rate of incorrect patient classification based on night-to-day ratio specification from singular 24-h ABPM in comparison to the results of 7-day ABPM monitoring. The percentage of blood pressure drop at night expressed by night-to-day ratio (dippers, non-dippers, extreme dippers, reverse dippers) can be specified much more accurately on the basis of 7-day ABPM values. ABPM restricted to 24 h, as currently practiced, does not yield a sufficiently reliable estimate of the night-to-day ratio for a classification in terms of dipping. Extending monitoring to 7 days accounts for the large day-to-day variability in the night-to-day ratio, and may yield a more reliable diagnosis of blood pressure variability.
1 - 7 days
Secondary Outcomes (1)
Optimalization of the blood pressure diagnostic through comparing of 24 hours and 7 days monitoring.
1 - 7 days
Study Arms (4)
Group 1
PLACEBO COMPARATORHealthy volunteers without exercise
Group 2
SHAM COMPARATORHealthy exercise-training volunteers
Group 3
ACTIVE COMPARATORPatients with ischemic coronary artery disease without exercise
Group 4
EXPERIMENTALPatients with ischemic coronary artery disease following cardiovascular rehabilitation
Interventions
The ambulatory monitoring (7-day ABPM) was performed with ambulatory blood pressure monitoring devices TM-2430 (A\&D; Tokyo, Japan) based on both the cuff-oscillometric and Korotkoff sound method. The cuff was placed on the non-dominant arm according to the same rules applying to casual auscultation measurement. The monitoring device with a weight of 250 g was worn by the monitored subjects in a waist-fixed case continuously for 7 days except for times involving personal hygiene. During every automatic measurement, the arm was resting and hung along the body. The device automatically recorded all the regular measurements for seven days, between 6:00 a.m. and 10:00 p.m. every 30 minutes and between 10:00 p.m. and 6:00 a.m. every 60 minutes. Such short intervals are necessary to obtain a sufficient number of representative measurements.
Combined aerobic-resistance exercise (group 2) was scheduled twice weekly in the form of 60-minute workouts with a load intensity at the level of sub-maximum heart frequency (75-85% SFmax). The minimum time span between the workouts was 24 hours. The workout consisted of a 10-minute warm-up, 25 minutes of aerobic exercise (spinning bicycle or bicycle ergometer), 15 minutes of resistance exercise on gym machines (bench press, leg extension and pull down) with 40-50% 1-RM (one repetition maximum) intensity (3 series of 10 exercises), and a 10-minute cool-down (stretching of the main muscle groups).
The cardiovascular exercise (group 4) took the form of sixty-minute workouts scheduled two to three times weekly. The nature of the workouts was similar, combined aerobic-resistance exercise (a 10-minute warm-up, aerobic endurance on bicycle ergo meter for 25 minutes, resistance exercise on multifunctional gym machines for 15 minutes, and a 10-minute cool-down). The workout intensity was set at the level of the first ventilation threshold (VAT-1), corresponding to the following workout parameters: load (W) and heart rate (HR).19,20 The resistance exercise intensity was specified by the 1-RM (one repetition maximum) method. The maximum load lifted across the full range of motion for every exercise was used as the benchmark for the workload intensity specification, corresponding to 30 - 60% 1-RM.
Eligibility Criteria
You may qualify if:
- Healthy volunteers (without any disease, including the cardiovascular ones, and without any kind of treatment)
- Patients with chronic ischemic coronary artery disease
- Patients treated with ACE inhibitors, beta-blockers or statins.
- To visit routinely in the health centres where the study is carried out
You may not qualify if:
- Age under 18 years,
- Pregnant, or breast-feeding,
- Patients on dialysis or being followed by nephrology,
- Severe physical or cognitive limitations,
- Intolerance to the method of measurement
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- St. Anne's University Hospital Brno, Czech Republiclead
- Masaryk Universitycollaborator
- University of Minnesotacollaborator
Study Sites (1)
St. Anne´s University Hospital Brno
Brno, 654 91, Czechia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 9, 2022
First Posted
March 3, 2022
Study Start
June 20, 2018
Primary Completion
June 25, 2020
Study Completion
June 20, 2021
Last Updated
March 3, 2022
Record last verified: 2022-02
Data Sharing
- IPD Sharing
- Will not share